It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit from immunotherapy, according to a preclinical study by Weill Cornell Medicine investigators.
FTC Settles With Private Equity Firm Over Anesthesia Investments
Last week, the Federal Trade Commission (FTC) announced a settlement with the private equity firm Welsh, Carson, Anderson & Stowe (WCAS), resolving a potential administrative